Treatment-resistant depression (TRD) refers to a form of major depressive disorder that does not adequately respond to multiple standard treatments for depression. These standard treatments typically include various antidepressant medications and psychotherapy approaches. When a person's depression symptoms persist or worsen despite undergoing multiple treatment trials, it is considered treatment-resistant.

Here are some common approaches used in the treatment of TRD:

Medication adjustments: If standard antidepressant medications have not been effective, the healthcare provider may consider changing the dosage, switching to a different medication, or combining multiple medications to target different aspects of depression. This may involve trying different classes of antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), or atypical antipsychotics.

Augmentation strategies: Augmentation involves adding a medication or treatment to enhance the effects of the existing antidepressant. This may include adding medications such as lithium, thyroid hormone, or atypical antipsychotics. Other augmentation strategies may involve utilizing non-pharmacological treatments like transcranial magnetic stimulation (TMS) or electroconvulsive therapy (ECT).

Psychotherapy: Different types of psychotherapy may be beneficial for treatment-resistant depression. Cognitive-behavioral therapy (CBT), dialectical behavior therapy (DBT), interpersonal therapy (IPT), and psychodynamic therapy are among the approaches that may be considered. These therapies can help individuals develop coping strategies, explore underlying issues, and manage depressive symptoms.